Skip to main content
    U

    USANA Health Sciences Inc (USNA)

    Official site

    CONSUMER DEFENSIVE • PACKAGED FOODS • NYSE

    $13.60
    +0.06 (+0.44%)

    Market Cap: $250.34M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    USANA Health Sciences Inc (USNA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    USANA Health Sciences (USNA) has a market cap of $250.34M and an enterprise value of $71.42M. It holds $178.91M more cash than debt, 71.47% of its market cap.

    Total Valuation

    Enterprise value is 71.47% below the market cap, as cash exceeds debt.

    Market Cap$250.34M
    Enterprise Value$71.42M
    Latest price (Nov 17, 2026)$13.60

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateNov 3, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.06% in the quarter ended Sep 30, 2026 and shrank 1.54% a year over 2 years.

    Shares Outstanding18.50M
    Shares Change (YoY)+1.12%
    Shares Change (QoQ)+0.06%
    Share Count Growth (2Y CAGR)-1.54%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 0.5x. Its year-end P/E ranged from 10.2x to 23.0x from 2016 to 2025.

    P/E Ratio13.2x
    Forward P/E24.2x
    P/S Ratio0.3x
    Forward P/S0.3x
    P/B Ratio0.5x
    P/TBV Ratio0.8x
    P/FCF Ratio8.5x
    P/OCF Ratio6.0x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 2.1x EBITDA and 2.5x free cash flow.

    EV / EBITDA2.1x
    EV / EBIT210.7x
    EV / FCF2.5x

    Price Statistics

    The stock is down 29.13% over 52 weeks and trades 5.82% below its 50-day average.

    Beta (1Y)0.72
    52-Week Change-29.13%
    1-Month Change-8.66%
    3-Month Change+2.64%
    6-Month Change-22.15%
    5-Year Change-85.26%
    10-Year Change-77.73%
    Total Return (1Y)-29.13%
    Total Return (3Y CAGR)-33.42%
    Total Return (5Y CAGR)-33.20%
    Return vs SPY (1Y)-39.06%
    Max Drawdown (1Y)-45.22%
    Max Drawdown (3Y)-76.62%
    Sharpe Ratio (1Y)-0.55
    Correlation with SPY (1Y)0.17
    50-Day Average$14.44
    200-Day Average$17.61
    52-Week Range$12.53 to $23.59
    RSI (14 Days)44.7
    Average Volume (20 Days)206.09K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.59x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.59x
    Quick Ratio1.84x
    Debt / Equity0.00x
    Interest Coverage50.32x

    Returns and Efficiency

    Return on equity is -4.02% over the last 12 months, against a 5-year average of 13.64%.

    Return on Equity (ROE)-4.02%
    Return on Assets (ROA)-2.99%
    Return on Capital Employed (ROCE)0.06%
    ROE (5Y Average)13.64%
    ROA (5Y Average)9.79%
    ROIC (5Y Average)14.27%
    Asset Turnover1.26x
    Inventory Turnover2.42x
    Receivables Turnover216.57x
    Cash Conversion Cycle123 days

    Scores

    USNA has an Altman Z-Score of 3.55, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score3.55
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $905.58M over the last 12 months is down 0.78% from the 12 months before.

    Revenue$905.58M
    Revenue Growth (YoY)-0.78%
    Gross Profit$699.68M
    Operating Income$9.68M
    Pretax Income-$62.00K
    Net Income-$21.20M
    EBITDA$34.80M
    EBIT$339.00K
    Reported EPS (TTM)$1.03

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 74.35% of the $708.47M in total assets.

    Cash and Equivalents$178.91M
    Total Debt$0
    Net Cash$178.91M
    Net Cash Per Share$9.67
    Working Capital$177.99M
    Shareholder Equity$526.76M
    Book Value Per Share$28.48
    Tangible Book Value$297.09M
    Tangible Book Per Share$16.06
    Total Assets$708.47M
    Total Liabilities$138.38M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $12.12M of capital spending, operating cash flow left $29.54M of free cash flow.

    Operating Cash Flow$41.65M
    Capital Expenditures$12.12M
    Free Cash Flow$29.54M
    FCF Per Share$1.60
    Depreciation and Amortization$34.35M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 1.07%, against a 5-year average of 9.70%.

    Gross Margin77.26%
    Operating Margin1.07%
    Pretax Margin-0.01%
    Net Margin-2.34%
    EBITDA Margin3.84%
    EBIT Margin0.04%
    FCF Margin3.26%
    Gross Margin (5Y Average)79.88%
    Operating Margin (5Y Average)9.70%
    Net Margin (5Y Average)5.95%

    Growth

    Revenue fell 2.51% a year over 3 years, and EPS 18.83% a year.

    Revenue Growth (3Y CAGR)-2.51%
    Revenue Growth (5Y CAGR)-4.00%
    EPS Growth (3Y CAGR)-18.83%
    EPS Growth (5Y CAGR)-20.00%
    FCF Growth (3Y CAGR)-54.99%
    FCF Growth (5Y CAGR)-43.29%
    Operating Income Growth (3Y CAGR)-22.11%
    Book Value Per Share Growth (2Y CAGR)+6.20%
    Tangible Book Per Share Growth (2Y CAGR)-21.76%

    Revenue and profit by year

    Dividends and Yields

    USNA does not pay a dividend. Its free cash flow yield is 11.74%.

    Earnings Yield7.58%
    FCF Yield11.74%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 2-for-1 forward split on Nov 23, 2016.

    Last Split DateNov 23, 2016
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 7 similar companies, USNA has the 4th highest P/E.

    P/E Ratio13.2x vs 12.7x median
    P/S Ratio0.3x vs 0.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)-0.78% vs +11.44% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -0.45% and EPS growth at -19.31% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-0.45%
    EPS Growth Forecast (2Y CAGR)-19.31%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About USNA

    What is USNA's market cap?

    USANA Health Sciences has a market cap of $250.34M. Its enterprise value, which adds debt and subtracts cash, is $71.42M.

    What is USNA's P/E ratio?

    USANA Health Sciences has a trailing P/E ratio of 13.2x and a forward P/E of 24.2x.

    How many shares of USNA are outstanding?

    USANA Health Sciences has 18.50M shares outstanding. The count is up 1.12% from a year earlier.

    Does USNA pay a dividend?

    No. USANA Health Sciences does not pay a dividend.

    How much debt does USNA have?

    USANA Health Sciences has $0 of total debt and $178.91M of cash and equivalents, a net cash position of $178.91M.